Avid Bioservices Inc., of Tustin, Calif., appointed Elie G. Hanania vice president, process development, viral vector technologies.

Neurobo Pharmaceuticals Inc., of Boston, named Gil Price president and CEO. He will also serve as interim chief medical officer.

Opgen Inc., of Rockville, Md., named Albert Weber chief financial officer of Opgen and managing director of the company’s subsidiary, Curetis GmbH, effective Jan. 1.

Progenity Inc., of San Diego, appointed Jill Howe to its board. She was also named chair of the audit committee and will serve on the nominating and corporate governance committee.

Provention Bio Inc., of Red Bank, N.J., appointed Thierry Chauche chief financial officer, effective Dec. 1.

Quoin Pharmaceuticals Ltd., of Ashburn, Va., named Gordon Dunn chief financial officer.

Santhera Pharmaceuticals AG, of Pratteln, Switzerland, appointed Stephanie Brown president North America and a member of its executive management team, effective Dec. 1.

Sunshine Biopharma Inc., of Montreal, appointed Andrew Tesley, JD Kish and Rabi Kiderchah to its board.